RESMED INC (RMD) Stock News
NYSE:RMD - New York Stock Exchange, Inc. - US7611521078 - Common Stock
RMD Latest News and Analysis
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the...
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr....
S&P 500 Movers: RMD, AVGO
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?
Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.
Interesting RMD Put And Call Options For February 2025
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
ResMed also boasts a superb 96 EPS Rating out of 99, putting it in the top 4% of all companies for recent and long-term profit growth.
ResMed Announces Participation in the UBS Global Healthcare Conference
ResMed Announces Participation in the UBS Global Healthcare Conference
SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr....
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
The major indexes were mixed for the week.
My 3 Favorite Stocks to Buy Right Now
Here are three attractive stocks to buy that will give you a healthy mix of growth and dividends.
Obesity Drugs-Tied ResMed Edges Higher On Quarterly Beat
The company beat fiscal first-quarter expectations. Shares are forming a flat base.
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27%Operating cash flow of $326 million Note: A webcast of ResMed’s...
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the...
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
2030 ambition to help more than 500 million people worldwide achieve their full health potentialShowcases integration of intelligent products and solutions...
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health ...
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health...
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort